Introduction: reproductive mental health--Motherisk update 2008.
On May 7th 2008, our annual Motherisk Update was devoted to reproductive mental health, which is a part of life for many women of childbearing age. Presentations were delivered by experts int he fields of psychiatry, maternal/fetal pharmacology and obstetrics. Our goal was to improve patient care for a population that is particularly vulnerable to misinformation and the stigma that surrounds mental illness. The topics presented, included the prevalence of depression and other psychiatric illnesses during pregnancy and postpartum, the adverse consequences of untreated psychiatric illnesses in pregnancy and postpartum and the treatment of substance abuse which is often a comorbidity in these women. We also provided information on the risk/safety of drugs used for the treatment of these conditions in pregnancy and breastfeeding,including concerns regarding neonatal withdrawal in infants who were exposed to antidepressants during pregnancy.
Einarson
Adrienne
A
The Motherisk Program, The Hospital for Sick Children, Toronto, Canada.
D001942:Breast Feeding / Q000009:adverse effects; D005260:Female; D006801:Humans; D007223:Infant; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology*; D008603:Mental Health; D008605:Mental Health Services / Q000458:organization & administration* / Q000592:standards; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000209:etiology*; D011619:Psychotropic Drugs / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000150:complications / Q000534:rehabilitation
D011619:Psychotropic Drugs